Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Novel Induction to Buprenorphine/Naloxone
NCT05644587Phase 4Terminated
- Sponsor
- Bicycle Health
- Start
- Feb 2023
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of buprenorphine + naloxone in opioid use disorder (OUD), sponsored by Bicycle Health. Started Feb 2023; status: terminated.
02
Drugs
buprenorphine + naloxone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT05644587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05644587.